N

Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538

Watchlist Manager
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Watchlist
Price: 13.09 CNY -5.56% Market Closed
Market Cap: 2.8B CNY
Have any thoughts about
Ningbo Menovo Pharmaceutical Co Ltd?
Write Note

Ningbo Menovo Pharmaceutical Co Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ningbo Menovo Pharmaceutical Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
N
Ningbo Menovo Pharmaceutical Co Ltd
SSE:603538
Tax Provision
ÂĄ8.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Tax Provision
-ÂĄ488.7m
CAGR 3-Years
3%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Tax Provision
-ÂĄ557.5m
CAGR 3-Years
-18%
CAGR 5-Years
-20%
CAGR 10-Years
-23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Tax Provision
-ÂĄ498.4m
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
-9%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Tax Provision
-ÂĄ700.5m
CAGR 3-Years
19%
CAGR 5-Years
-43%
CAGR 10-Years
-5%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Tax Provision
-ÂĄ11.5m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Ningbo Menovo Pharmaceutical Co Ltd
Glance View

Market Cap
2.9B CNY
Industry
Pharmaceuticals

Ningbo Menovo Pharmaceutical Co., Ltd. engages in the research, development, testing, production, and sale of pharmaceutical products. The company is headquartered in Ningbo, Zhejiang and currently employs 2,473 full-time employees. The company went IPO on 2017-04-07. The Company’s products contain gastropathic medicine and cardiovascular medicine, which include anti-hypertension medicine, anti-hyperlipidemia medicine and anti-thrombus medicine. The firm distributes its products to both domestic and overseas markets.

Intrinsic Value
12.45 CNY
Overvaluation 5%
Intrinsic Value
Price
N

See Also

What is Ningbo Menovo Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
8.2m CNY

Based on the financial report for Dec 31, 2023, Ningbo Menovo Pharmaceutical Co Ltd's Tax Provision amounts to 8.2m CNY.

Back to Top